首页> 美国卫生研究院文献>Cancer Management and Research >Overexpression of PDK4 is associated with cell proliferation drug resistance and poor prognosis in ovarian cancer
【2h】

Overexpression of PDK4 is associated with cell proliferation drug resistance and poor prognosis in ovarian cancer

机译:PDK4的过度表达与卵巢癌的细胞增殖耐药性和预后不良有关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

PurposeOvarian cancer is a major type of gynecological malignancy which characterized by the chemoresistance, heterogeneity and highly metastasis. However, the mechanism underlying the progression of ovarian cancer remains elusive. Pyruvate dehydrogenase kinase family plays critical roles in tumorigenesis, and PDK4 has been demonstrated to be an oncogene in many types of cancers. The aim of this study was to identify the role of PDK4 in ovarian cancer.
机译:目的卵巢癌是妇科恶性肿瘤的主要类型,其特征是化学耐药性,异质性和高度转移。但是,卵巢癌进展的潜在机制仍然难以捉摸。丙酮酸脱氢酶激酶家族在肿瘤发生中起关键作用,PDK4已被证明是许多类型癌症中的癌基因。这项研究的目的是确定PDK4在卵巢癌中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号